Janney Montgomery Scott
NVAX icon

Janney Montgomery Scott’s Novavax NVAX Stock Holding History

Janney Montgomery Scott’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-116,860
Closed -$1.01M – 2986
2025
Q3 		$1.01M Buy
+116,860
New +$909K ﹤0.01% 1683
2022
Q1 		– Sell
-7,414
Closed -$1.06M – 2372
2021
Q4 		$1.06M Buy
7,414
+206
+3% +$35.4K ﹤0.01% 1294
2021
Q3 		$1.49M Buy
7,208
+3,168
+78% +$698K 0.01% 1088
2021
Q2 		$858K Buy
4,040
+379
+10% +$69.4K ﹤0.01% 1347
2021
Q1 		$664K Buy
3,661
+1,725
+89% +$344K ﹤0.01% 1404
2020
Q4 		$216K Buy
+1,936
New +$206K ﹤0.01% 2065

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janney Montgomery Scott's NVAX Position: Q4 2025 in Review

Janney Montgomery Scott sold out of Novavax (NVAX) in Q4 2025, closing a stake of 116,860 shares — an estimated $1.01M sold.

Janney Montgomery Scott first reported a position in NVAX in Q4 2020 and held it in 6 quarters. The position peaked at $1.49M in Q3 2021. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • Janney Montgomery Scott reported no remaining Novavax position as of Q4 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 116,860 Novavax shares in Q4 2025, an estimated $1.01M.
  • Janney Montgomery Scott first reported a position in Novavax in Q4 2020 and held it in 6 quarters.
  • Janney Montgomery Scott's Novavax position peaked at $1.49M in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on Janney Montgomery Scott's 13F filing for Q4 2025, filed 11 Feb 2026.